Vol. 13 No. 3 (2021)

Artigos

• Approaches to horizon scanning and technological prospecting in medical devices

  Fotini Toscas

  236-241

  • PDF (Português (Brasil))

• Trifluridine/tipiracil hydrochloride in the treatment of polytreated metastatic colorectal carcinoma: a cost-effectiveness analysis in the private payer perspective in Brazil

  Fernando Vieira, Ana Paula Victorino, Kelly Araújo, Bianca Oesterreicher, Pedro Lima, Luciana Mardegan, Sandro Albuquerque, Juliana Vasconcellos

  242-252

  • PDF (Português (Brasil))

• Pharmacoeconomic profile of the treatment of idiopathic pulmonary fibrosis demanded by the elderly in the state of Pará

  Agnes Kaminosono, Ana Maria Gillet, Emanuelle Sousa, Jocileide Gomes, Orenzio Soler

  253-257

  • PDF (Português (Brasil))

• Immunotherapy-based first-line treatment of intermediate- and poor-risk advanced renal cell carcinoma: number needed to treat and cost of preventing an event from the perspective of the Brazilian private healthcare system

  Ana Paula Oliveira, Camila Roubik, Matthew Dyer, Lucienne Neusquen, Miriam Marcolino, Rodrigo Ribeiro, Jessica May

  258-267

  • PDF (Português (Brasil))

• Cladribine tablets for the treatment of highly active recurrent multiple sclerosis: budget impact analysis from the perspective of the Brazilian supplementary health system

  Leticia Jabase, Gabriel Marasco, Ana Carolina Ribeiro-Pereira, Leonardo Camargo, Giovanna Puopolo, Roberta Fernandes, Alexandre Chehin

  268-278

  • PDF (Português (Brasil))

• Demographic characteristics and use of resources by patients with atopic dermatitis in the Brazilian Unified Health System (SUS)

  André Santos, Aline Barbosa, Alexandre Taminato, Isabelle Malbouisson, Fernando Laredo

  279-287

  • PDF (Português (Brasil))

• Evaluation of costs associated with fragility fractures in the Brazilian Unified Health System (SUS) and the Supplementary Health System (SSS)

  Luciana Mensor, Mariana Rosim, Gabriel Marasco, Deborah Rigo, Thiago Marchesan, Roberta Arinelli

  288-299

  • PDF (Português (Brasil))

• Economic impact of influenza infection in Brazil: analysis from the health systems and society perspective in 2019

  Rafael Araújo, Sarah Watanabe, Louis Boiron, Ana Carolina Pereira, Enzo Asano

  300-309

  • PDF (Português (Brasil))

• Epidemiology and burden of treatment-resistant depression in Brazil: analysis of the Brazilian subset of multicenter observational TRAL study

  Chei Teng, Marco Antonio Caldieraro, Acioly Lacerda, Antonio Nardi, Lucas Quarantini, Fabio Souza, Humberto Correa, Gabriela Kanevsky, Patricia Cabrera

  310-321

  • PDF (Português (Brasil))

• Criteria for setting drug prices in Brazil and selected countries: a comparative review

  Melissa Farias, Márcia Pinto

  322-337

  • PDF (Português (Brasil))

• Direct and indirect costs of fibromyalgia: a scoping review

  Fernanda Alberti, Carine Blatt, Diogo Pilger

  338-344

  • PDF (Português (Brasil))

• Determinants of the COVID-19 recovery rate: a case study for the municipality of Belo Horizonte – MG

  Sinara Anastácio, Lídia Silveira, Adriano Gomes

  345-355

  • PDF (Português (Brasil))